{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T22:55:35Z","timestamp":1782255335658,"version":"3.54.5"},"reference-count":20,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":2682,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer"],"published-print":{"date-parts":[[2008,6,25]]},"DOI":"10.1002\/cncr.23496","type":"journal-article","created":{"date-parts":[[2008,4,28]],"date-time":"2008-04-28T18:19:48Z","timestamp":1209406788000},"page":"196-203","source":"Crossref","is-referenced-by-count":15,"title":["Quantitative detection of molecular markers ProEx C (minichromosome maintenance protein 2 and topoisomerase IIa) and MIB-1 in liquid-based cervical squamous cell cytology"],"prefix":"10.1002","volume":"114","author":[{"given":"Maria Donatella","family":"Beccati","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Buriani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Pedriali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Italo","family":"Nenci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2008,4,28]]},"reference":[{"key":"10.1002\/cncr.23496-BIB1|cit1","first-page":"361","article-title":"Risk-adapted multimodal laboratory cervical screening-application of new technologies to cervical cancer prevention","volume":"46","author":"Bollmann","year":"2005","journal-title":"Croat Med J."},{"issue":"suppl","key":"10.1002\/cncr.23496-BIB2|cit2","doi-asserted-by":"crossref","first-page":"17","DOI":"10.2144\/05384SU03","article-title":"Molecular diagnostic assays for cervical neoplasia: emerging markers for the detection of high-grade cervical disease","author":"Malinowski","year":"2005","journal-title":"Biotechniques."},{"key":"10.1002\/cncr.23496-BIB3|cit3","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1097\/01.grf.0000151584.78239.89","article-title":"Emerging technology in cervical cancer screening: status of molecular markers","volume":"48","author":"Padilla-Paz","year":"2005","journal-title":"Clin Obstet Gynecol."},{"key":"10.1002\/cncr.23496-BIB4|cit4","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1136\/jcp.2005.027839","article-title":"Dynamic behavioural interpretation of cervical intraepithelial neoplasia with molecular biomarkers","volume":"59","author":"Baak","year":"2006","journal-title":"J Clin Pathol."},{"key":"10.1002\/cncr.23496-BIB5|cit5","first-page":"5","article-title":"Immunohistochemistry in assessment of molecular pathogenesis of cervical carcinogenesis","volume":"26","author":"Syrjanen","year":"2005","journal-title":"Eur J Gynaecol Oncol."},{"key":"10.1002\/cncr.23496-BIB6|cit6","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1038\/modpathol.3800361","article-title":"Quantitation of CDC6 and MCM5 mRNA in cervical intraepithelial neoplasia and invasive squamous cell carcinoma of the cervix","volume":"18","author":"Murphy","year":"2005","journal-title":"Mod Pathol."},{"key":"10.1002\/cncr.23496-BIB7|cit7","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1136\/jcp.2004.018895","article-title":"p16INK4A, CDC6, and MCM5: predictive biomarkers in cervical preinvasive neoplasia and cervical cancer","volume":"58","author":"Murphy","year":"2005","journal-title":"J Clin Pathol."},{"issue":"1-3","key":"10.1002\/cncr.23496-BIB8|cit8","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0167-4781(98)00132-8","article-title":"Mechanism of action of eukaryotic topoisomerase II and drugs targeted to the enzyme","volume":"1400","author":"Burden","year":"1998","journal-title":"Biochim Biophys Acta."},{"key":"10.1002\/cncr.23496-BIB9|cit9","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/01.pgp.0000209573.54457.32","article-title":"Over-expression of topoisomerase IIalpha is related to the grade of cervical intraepithelial neoplasia (CIN) and high-risk human papillomavirus (HPV), but does not predict prognosis in cervical cancer or HPV clearance after cone treatment","volume":"25","author":"Branca","year":"2006","journal-title":"Int J Gynecol Pathol."},{"key":"10.1002\/cncr.23496-BIB10|cit10","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.virol.2004.09.045","article-title":"Gene expression profiles of primary HPV16-and HPV18-infected early stage cervical cancers and normal cervical epithelium: identification of novel candidate molecular markers for cervical cancer diagnosis and therapy","volume":"331","author":"Santin","year":"2005","journal-title":"Virology."},{"key":"10.1002\/cncr.23496-BIB11|cit11","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1046\/j.1432-1033.2003.03440.x","article-title":"Enhanced expression of Mcm proteins in cancer cells derived from uterine cervix","volume":"270","author":"Ishimi","year":"2003","journal-title":"Eur J Biochem."},{"key":"10.1002\/cncr.23496-BIB12|cit12","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1098\/rstb.2005.1656","article-title":"The Croonian Lecture 2001 hunting the antisocial cancer cell: MCM proteins and their exploitation","volume":"360","author":"Laskey","year":"2005","journal-title":"Phil Trans R Soc London B Biol Sci."},{"issue":"pt 8","key":"10.1002\/cncr.23496-BIB13|cit13","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1242\/jcs.114.8.1447","article-title":"Initiating DNA synthesis: from recruiting to activating the MCM complex","volume":"114","author":"Lei","year":"2001","journal-title":"J Cell Sci."},{"key":"10.1002\/cncr.23496-BIB14|cit14","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1083\/jcb.123.3.513","article-title":"The cell proliferation-associated antigen of antibody Ki-67: a very large, ubiquitous nuclear protein with numerous repeated elements, representing a new kind of cell cycle-maintaining proteins","volume":"123","author":"Schluter","year":"1993","journal-title":"J Cell Biol."},{"key":"10.1002\/cncr.23496-BIB15|cit15","first-page":"134","article-title":"Evaluation of prospective, routine application of Ki-67 immunoquantitation in early CIN for assessment of short-term progression risk","volume":"26","author":"Kruse","year":"2004","journal-title":"Anal Quant Cytol Histol."},{"key":"10.1002\/cncr.23496-BIB16|cit16","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1002\/path.1316","article-title":"Low- and high-risk CIN 1 and 2 lesions: prospective predictive value of grade, HPV, and Ki-67 immuno-quantitative variables","volume":"199","author":"Kruse","year":"2003","journal-title":"J Pathol."},{"key":"10.1002\/cncr.23496-BIB17|cit17","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1002\/path.998","article-title":"Relationship between the presence of oncogenic HPV DNA assessed by polymerase chain reaction and Ki-67 immunoquantitative features in cervical intraepithelial neoplasia","volume":"195","author":"Kruse","year":"2001","journal-title":"J Pathol."},{"key":"10.1002\/cncr.23496-BIB18|cit18","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/1096-9896(2000)9999:9999<::AID-PATH719>3.0.CO;2-E","article-title":"Ki-67 immunoquantitation in cervical intraepithelial neoplasia (CIN): a sensitive marker for grading","volume":"193","author":"Kruse","year":"2001","journal-title":"J Pathol."},{"key":"10.1002\/cncr.23496-BIB19|cit19","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1002\/cncr.22288","article-title":"Detection of cervical high-grade squamous sintraepithelial lesions from cytologic samples using a novel immunocytochemical assay (ProEx\u2122 C)","volume":"108","author":"Kelly","year":"2006","journal-title":"Cancer."},{"key":"10.1002\/cncr.23496-BIB20|cit20","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1002\/cncr.22171","article-title":"Validation of a novel immunocytochemical assay for topoisomerase II-alpha and minichromosome maintenance protein 2 expression in cervical cytology","volume":"108","author":"Shroyer","year":"2006","journal-title":"Cancer."}],"container-title":["Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fcncr.23496","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/cncr.23496","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,9]],"date-time":"2021-09-09T02:24:16Z","timestamp":1631154256000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/cncr.23496"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,4,28]]},"references-count":20,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,6,25]]}},"URL":"https:\/\/doi.org\/10.1002\/cncr.23496","relation":{},"ISSN":["0008-543X"],"issn-type":[{"value":"0008-543X","type":"print"}],"subject":[],"published":{"date-parts":[[2008,4,28]]}}}